nerve molecule red w logo 3.jpg

The largest not-for-profit scientific network of Parkinson centers in North America


Parkinson Study Group has carried out cooperative therapeutic research since 1986, beginning with the NIH-sponsored DATATOP (Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism) clinical trial. Since then we have carried out more than 35 multi-center trials examining the symptomatic and neuroprotective effects of experimental interventions in Parkinson disease. The PSG has partnered with numerous pharmaceutical companies and the National Institutes of Health (NIH) in bringing new drugs for Parkinson disease to the market including pramipexole, entacapone, rotigotine and rasagiline.

Funding Resources img

Funding Resources

A collection of grants, awards and other funding available for Parkinson Disease research initiatives

Clinical Trials img

Clinical Trials

Clinical trials in progress, completed trials, PSG credentialed sites and other related resources

Study Kit img

Study Proposal Toolkit

Procedures, forms, sample projects and more, for those seeking to submit a study proposal

Upcoming Funding Opportunities!

The PSG is currently offering two RFPs:


Request for Proposals for a Mentored Clinical Research Award for new investigators in patient oriented research in Parkinson disease and related disorders, due 1/6/17. An award of $50,000 is available this year.

Download the RFP for further details.

Request for Research Proposals and for Retrospective Data-Mining Projects in Parkinson’s Disease and Related Disorders, due 12/1/16. There is funding available up to $39,000 this review cycle.

Download the RFP for further details.


Upcoming Events & Deadlines